Viscosupplementation Market To Surpass USD 5.3 Billion By 2026

1
Viscosupplementation Market To Surpass USD 5.3
Billion By 2026 Global Market Insights, Inc.
2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
2

• Viscosupplementation Market Scenario

• According to a research report by Global Market
  Insights Inc, the global viscosupplementation
  market is likely to surpass a valuation of 5.3
  billion by 2026.
• The global viscosupplementation market is
  anticipated to observe substantial growth due to
  the increasing instances of osteoarthritis
  throughout the global geriatric population.
  Osteoarthritis typically affects the joints in
  hands, knees, spine, and hips, and is responsible
  for generating high healthcare costs among its
  patients. Among these, knee osteoarthritis is the
  most common type of arthritis, affecting millions
  of people globally.
• In terms of the product, the overall
  viscosupplementation market is classified into 5
  injections, 3 injections, and single injection.
  Among these, the 3 injections segment is
  projected to record tremendous growth over the
  coming years due to the increasing adoption as
  well as availability of numerous commercialized
  products for osteoarthritis treatment. In fact,
  the segment held a valuation of more than 1.3
  billion in 2019.

2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
3
Continue-

• The 3 injections treatment is administered
  through weekly intervals and can effectively
  reduce the amount of pain experienced by the
  patient within weeks. As a result of the
  aforementioned factors, the increasing demand for
  3 injections is likely to impel the segment
  share, thereby fostering overall market size.
• With respect to end-use, the hospitals segment
  represented an overall industry share of more
  than 59 in 2019. The immense segment share is
  attributed to the rising number of hospitals
  across the world. In addition, the increasing
  availability of effective viscosupplementation
  treatments for osteoarthritis patients in
  hospitals would further drive the segment size.

Request sample copy of content of this Report _at_
https//www.gminsights.com/request-sample/detail/4
212
2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
4

• Regional Analysis

• On the regional front, the Spain
  viscosupplementation market is estimated to
  foresee significant revenue growth due to factors
  like increasing geriatric population and growing
  number of osteoarthritis cases in that
  demographic. In fact, as per recently published
  data, more than 7 million people are suffering
  from osteoarthritis in the country with many
  needing viscosupplementation treatments to
  alleviate the amount of pain in their joints.

• Competitive Analysis

• The competitive landscape of the global
  viscosupplementation market is inclusive of
  players such as Genzyme Corporation, Wellchem
  Pharmaceuticals, Zimmer Biomet, Mylan Inc.,
  Johnson Johnson Services, Chugai Pharmaceutical
  Co., Bioventus, Aptissen, and Anika Therapeutics
  among others.

Request for customization https//www.gminsights.
com/roc/4212
2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
5
Latest Research Report on Viscosupplementation
Market _at_ https//www.gminsights.com/industry-analy
sis/viscosupplementation-market Request sample
copy of this research report_at_ https//www.gminsigh
ts.com/request-sample/detail/4212 Request for
customization https//www.gminsights.com/roc/421
2
2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
6
Stay In Touch You can visit us at
www.gminsights.com
Thank You!
2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
www.gminsights.com